Exhaled Breath Aerosol for the Etiological Diagnosis of Respiratory Tract Infections: a Pilot Study

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

December 12, 2024

Conditions
Respiratory Diseases
Interventions
DEVICE

medical device for exhaled breath aerosols (XBAs) collection

To evaluate the feasibility of XBAs collection and analysis (index test) using the molecular tests currently in use at San Raffaele Hospital for the detection of respiratory pathogens in clinical samples, compared to upper respiratory secretion and sputum samples, that will be collected using standard procedures and analysed using the same kits (comparator tests).

Trial Locations (1)

20132

Emerging Bacterial Pathogens Unit, Milan

All Listed Sponsors
lead

Ospedale San Raffaele

OTHER

NCT06229613 - Exhaled Breath Aerosol for the Etiological Diagnosis of Respiratory Tract Infections: a Pilot Study | Biotech Hunter | Biotech Hunter